Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway

Shuping You, Weihong Li, Yun Guan

Open source

DOI
10.3892/mmr.2018.8444
Published
2018-01-17
Container
Molecular Medicine Reports
Publisher
Spandidos Publications
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/mmr.2018.8444,
  title = {Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway},
  author = {Shuping You and Weihong Li and Yun Guan},
  year = {2018},
  journal = {Molecular Medicine Reports},
  doi = {10.3892/mmr.2018.8444},
  url = {https://doi.org/10.3892/mmr.2018.8444}
}

RIS

TY  - JOUR
TI  - Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway
AU  - Shuping You
AU  - Weihong Li
AU  - Yun Guan
PY  - 2018
JO  - Molecular Medicine Reports
DO  - 10.3892/mmr.2018.8444
UR  - https://doi.org/10.3892/mmr.2018.8444
ER  - 

APA

You, S., Li, W., & Guan, Y. (2018). Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2018.8444

Source records